Lv1
30 积分 2024-09-24 加入
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2天前
已完结
Behavioural interventions to increase uptake of FIT colorectal screening in Scotland (TEMPO): a nationwide, eight-arm, factorial, randomised controlled trial
2天前
已完结
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial
3天前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
3天前
已完结
皖公网安备34019202002308
